Background Cervical cancer screening coverage is a key monitoring indicator of the WHO
cervical cancer elimination plan. We present global, regional, and national cervical …

Screening for Cervical Cancer This article reviews recent evidence from the International
Agency for Research on Cancer on the best methods of screening for cervical cancer …

Background The knowledge that persistent human papillomavirus (HPV) infection is the
main cause of cervical cancer has resulted in the development of prophylactic vaccines to …

Rebecca B. Perkins, MD, MSc, 1 Richard S. Guido, MD, 2 Philip E. Castle, PhD, 3 David
Chelmow, MD, 4 Mark H. Einstein, MD, MS, 5 Francisco Garcia, MD, MPH, 6 Warner K. Huh …

An increasing body of evidence supports the validity of self-sampling as an alternative to
clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling …

Objective To evaluate the diagnostic accuracy of high-risk human papillomavirus (hrHPV)
assays on self samples and the efficacy of self sampling strategies to reach underscreened …

Infections with human papillomavirus (HPV) are common and transmitted by direct contact.
Although the great majority of infections resolve within 2 years, 13 phylogenetically related …

Background Only clinically validated HPV assays can be accepted in cervical cancer
screening. Objectives To update the list of high-risk HPV assays that fulfil the 2009 …

Background Meta-analyses have become an essential tool in synthesizing evidence on
clinical and epidemiological questions derived from a multitude of similar studies assessing …

Cervical cancer is the fourth most frequently occurring cancer in women around the world
and can affect them during their reproductive years. Since the development of the …